Literature DB >> 18349131

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Thomas Skripuletz1, Maren Lindner, Alexandra Kotsiari, Niklas Garde, Jantje Fokuhl, Franziska Linsmeier, Corinna Trebst, Martin Stangel.   

Abstract

The cuprizone model of toxic demyelination in the central nervous system is commonly used to investigate the pathobiology of remyelination in the corpus callosum. However, in human demyelinating diseases such as multiple sclerosis, recent evidence indicates a considerable amount of cortical demyelination in addition to white matter damage. Therefore, we have investigated cortical demyelination in the murine cuprizone model. To induce demyelination, C57BL/6 mice were challenged with 0.2% cuprizone feeding for 6 weeks followed by a recovery phase of 6 weeks with a cuprizone-free diet. In addition to the expected demyelination in the corpus callosum, the cortex of C57BL/6 mice was completely demyelinated after 6 weeks of cuprizone feeding. After withdrawal of cuprizone the cortex showed complete remyelination similar to that in the corpus callosum. When C57BL/6 mice were fed cuprizone for a prolonged period of 12 weeks, cortical remyelination was significantly delayed. Because interstrain differences have been described, we also investigated the effects of cuprizone on cortical demyelination in BALB/cJ mice. In these mice, cortical demyelination was only partial. Moreover, cortical microglia accumulation was markedly increased in BALB/cJ mice, whereas microglia were absent in the cortex of C57BL/6 mice. In summary, our results show that cuprizone feeding is an excellent model in which to study cortical demyelination and remyelination, including contributing genetic factors represented by strain differences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349131      PMCID: PMC2276412          DOI: 10.2353/ajpath.2008.070850

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Cortical lesions in multiple sclerosis.

Authors:  D Kidd; F Barkhof; R McConnell; P R Algra; I V Allen; T Revesz
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

2.  Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 3.  Microglia in health and disease.

Authors:  Seung U Kim; Jean de Vellis
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

4.  Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.

Authors:  Leonie A Boven; Marjan Van Meurs; Marloes Van Zwam; Annet Wierenga-Wolf; Rogier Q Hintzen; Rolf G Boot; Johannes M Aerts; Sandra Amor; Edward E Nieuwenhuis; Jon D Laman
Journal:  Brain       Date:  2005-12-19       Impact factor: 13.501

Review 5.  Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.

Authors:  D G Walker; L-F Lue
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

6.  Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction.

Authors:  S M Rao; G J Leo; L Bernardin; F Unverzagt
Journal:  Neurology       Date:  1991-05       Impact factor: 9.910

7.  Cortical demyelination and diffuse white matter injury in multiple sclerosis.

Authors:  Alexandra Kutzelnigg; Claudia F Lucchinetti; Christine Stadelmann; Wolfgang Brück; Helmut Rauschka; Markus Bergmann; Manfred Schmidbauer; Joseph E Parisi; Hans Lassmann
Journal:  Brain       Date:  2005-10-17       Impact factor: 13.501

8.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.

Authors:  L Xiao; H Xu; Y Zhang; Z Wei; J He; W Jiang; X Li; L E Dyck; R M Devon; Y Deng; X M Li
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

9.  Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

Authors:  M M Hiremath; Y Saito; G W Knapp; J P Ting; K Suzuki; G K Matsushima
Journal:  J Neuroimmunol       Date:  1998-12-01       Impact factor: 3.478

10.  Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression.

Authors:  Mark R Kotter; Chao Zhao; Nico van Rooijen; Robin J M Franklin
Journal:  Neurobiol Dis       Date:  2005-02       Impact factor: 5.996

View more
  95 in total

1.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

2.  In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.

Authors:  Ileana O Jelescu; Magdalena Zurek; Kerryanne V Winters; Jelle Veraart; Anjali Rajaratnam; Nathanael S Kim; James S Babb; Timothy M Shepherd; Dmitry S Novikov; Sungheon G Kim; Els Fieremans
Journal:  Neuroimage       Date:  2016-02-11       Impact factor: 6.556

3.  IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.

Authors:  Julian Zimmermann; Michael Emrich; Marius Krauthausen; Simon Saxe; Louisa Nitsch; Michael T Heneka; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

4.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Authors:  Katharina Janssen; Mira Rickert; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-02-08       Impact factor: 5.590

5.  Evaluation of [¹²³I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation.

Authors:  Filomena Mattner; David Linares Bandin; Maria Staykova; Paula Berghofer; Marie Claude Gregoire; Patrice Ballantyne; Mitchell Quinlivan; Susan Fordham; Tien Pham; David O Willenborg; Andrew Katsifis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

6.  Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Authors:  Johannes Goldberg; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

7.  Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Authors:  Steven M Wellman; Kelly Guzman; Kevin C Stieger; Lauren E Brink; Sadhana Sridhar; Mitchell T Dubaniewicz; Lehong Li; Franca Cambi; Takashi D Y Kozai
Journal:  Biomaterials       Date:  2020-02-06       Impact factor: 12.479

Review 8.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

9.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

Authors:  Martine El-Etr; Marion Rame; Celine Boucher; Abdel M Ghoumari; Narender Kumar; Philippe Liere; Antoine Pianos; Michael Schumacher; Regine Sitruk-Ware
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

10.  Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.

Authors:  Zhifang Li; Yangtao He; Shuangyi Fan; Binbin Sun
Journal:  Neurosci Bull       Date:  2015-08-06       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.